| Broad hepatitis C treatment scenarios return substantial health gains, but capacity is a concern K Van Nuys, R Brookmeyer, JW Chou, D Dreyfus, D Dieterich, ... Health Affairs 34 (10), 1666-1674, 2015 | 44 | 2015 |
| Hospital readmission rates among patients with schizophrenia treated with long-acting injectables or oral antipsychotics JP MacEwan, SA Kamat, RA Duffy, S Seabury, JW Chou, SN Legacy, ... Psychiatric Services 67 (11), 1183-1188, 2016 | 41 | 2016 |
| Challenges and opportunities in insomnia disorder M Roach, T Juday, R Tuly, JW Chou, AB Jena, PP Doghramji International Journal of Neuroscience 131 (11), 1058-1065, 2021 | 39 | 2021 |
| Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases D Incerti, XM Xu, JW Chou, N Gonzaludo, JW Belmont, BE Schroeder Genetics in Medicine 24 (1), 109-118, 2022 | 33 | 2022 |
| Value of improved lipid control in patients at high risk for adverse cardiac events AB Jena, DM Blumenthal, W Stevens, JW Chou, TG Ton, DP Goldman Am J Manag Care 22 (6), e199-e207, 2016 | 25 | 2016 |
| Evaluating expected costs and benefits of granting access to new treatments on the basis of progression-free survival in non–small-cell lung cancer DN Lakdawalla, JW Chou, MT Linthicum, JP MacEwan, J Zhang, ... JAMA oncology 1 (2), 196-202, 2015 | 25 | 2015 |
| The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions K Bognar, JA Romley, JP Bae, J Murray, JW Chou, DN Lakdawalla Journal of Health Economics 51, 1-12, 2017 | 23 | 2017 |
| Short-term budget affordability of hepatitis C treatments for state Medicaid programs JW Chou, AR Silverstein, DP Goldman BMC Health Services Research 19, 1-13, 2019 | 20 | 2019 |
| Unintended consequences of the potential phase-out of gamma irradiation JW Chou, M Skornicki, JT Cohen F1000research 7, 2018 | 19 | 2018 |
| The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma J Shafrin, J Sullivan, JW Chou, MN Neely, JF Doan, JR Maclean Cancer management and research, 731-739, 2017 | 11 | 2017 |
| Evaluating HCV screening, linkage to care, and treatment across insurers K Mulligan, J Sullivan, L Yoon, J Chou, K Van Nuys Am J Manag Care 24 (8), e257-e64, 2018 | 10 | 2018 |
| Why published studies of the cost-effectiveness of PCSK-9 inhibitors yielded such markedly different results PP Toth, W Stevens, JW Chou Journal of medical economics 20 (7), 749-751, 2017 | 10 | 2017 |
| Financial implications of a hospital early mobility program K Bognar, JW Chou, D McCoy, AL Sexton Ward, J Hester, P Guin, ... Intensive Care Medicine Experimental 3, 1-1, 2015 | 7 | 2015 |
| Understanding and improving value frameworks with real-world patient outcomes AB Jena, JW Chou, L Yoon, WM Aubry, J Berger, W Burton, AM Fendrick, ... Am J Manag Care 24 (11), 506-9, 2018 | 5 | 2018 |
| Challenges and opportunities in atypical parkinsonian syndromes: Call to action M Roach, JW Chou, B Lavin, JR Maclean Research and Reviews in Parkinsonism, 1-6, 2020 | 4 | 2020 |
| Expert consensus established around flexible, individualized migraine treatment utilizing a modified Delphi panel M Graf, E Kim, I Brewer, J Hernandez, JW Chou, J Cirillo, C Jensen, ... Headache: The Journal of Head and Face Pain 63 (4), 506-516, 2023 | 3 | 2023 |
| Schizophrenia population health management: perspectives of and lessons learned from population health decision makers M Roach, D Lin, M Graf, P Pednekar, JW Chou, C Benson, JA Doshi Journal of Managed Care & Specialty Pharmacy 27 (10-a Suppl), S1-S13, 2021 | 3 | 2021 |
| The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma JP MacEwan, I Majer, JW Chou, S Panjabi Therapeutic Advances in Hematology 12, 20406207211027463, 2021 | 3 | 2021 |
| Public-private partnership as a path to affordable healthcare in emerging markets JW Chou, DN Lakdawalla, J Vanderpuye-Orgle Forum for Health Economics and Policy 18 (1), 65-74, 2015 | 3 | 2015 |
| Challenges and opportunities in atypical parkinsonian syndromes: Call to action. Research and Reviews in Parkinsonism, 10, 1-6 M Roach, JW Chou, B Lavin, JR Maclean | 2 | 2020 |
